Track topics on Twitter Track topics that are important to you
Cardinal Health Inc. shares declined 3% in premarket trade Wednesday after the company reported fourth quarter profit and revenue beats but issued downbeat 2018 guidance. Earnings for the latest quarter declined to $274 million, or 86 cents per share, from $333 million, or $1.02 per share in the year-earlier period.
Original Article: Cardinal Health stock drops 3% on downbeat fiscal 2018 guidanceNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...